Alexis Pinto
General Counsel, Zentalis Pharmaceuticals, Inc.
Companies
- Zentalis Pharmaceuticals, Inc.General counsel Sep 1, 2020 to Feb 14, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Zentalis Pharmaceuticals, Inc. ZNTL22,240 shares2$50.9K at $2.29Feb 14, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 14, 2022Sold 77 shares at $50.75 of Zentalis Pharmaceuticals, Inc.2
- Feb 14, 2022Sold 614 shares at $50.16 of Zentalis Pharmaceuticals, Inc.2
- Feb 10, 2022Granted 16,405 shares of Zentalis Pharmaceuticals, Inc.2
- Oct 25, 2021Sold 300 shares at $78.85 of Zentalis Pharmaceuticals, Inc.3
- Oct 25, 2021Sold 19,802 shares at $78.05 of Zentalis Pharmaceuticals, Inc.3
- Oct 25, 2021Sold 8,098 shares at $77.27 of Zentalis Pharmaceuticals, Inc.3
- Oct 25, 2021Sold 1,800 shares at $76.10 of Zentalis Pharmaceuticals, Inc.3
- Oct 25, 2021Exercised options 30,000 shares at $34.40 of Zentalis Pharmaceuticals, Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Oct 27, 2021